Why clarity matters as much as access in healthcare

Patients
Doctor explains options to patient

Launch day can feel like crossing the finish line. We’ve made a service available to millions, and it makes a great news headline. It’s also a real achievement; in the United States especially, cost is a major barrier to getting care, so getting a service covered through a health plan or an employer matters. Granting access to a new service can drive affordability and, in theory, can help overcome health equity barriers.

But accessibility is a different question. Amidst all the noise with healthcare services and benefits, do I even realise this service is available to me? Can I get to the benefit I actually need, when I need it? And do I know what to use, and when to use it?

I saw this in a previous role leading growth at a digital mental-health company. We offered mental health support at no cost and people could access it in about one minute. On paper, that’s about as accessible as it gets. It still wasn’t enough.

First, we had to learn how to communicate the benefit. Even a small shift from “you have a free benefit” to “this is available at no cost to you, sponsored by your employer” made it feel like something worth having, of value to them.

The harder part was stigma. Plenty of people don’t identify anxiety as anxiety. They may say they can’t sleep or describe physical pain without connecting those symptoms to mental health. Saying, “I had trouble sleeping last night” is still easier to identify with than “I had anxiety last night”. In that case, messaging about the value of the benefit as “help sleeping” made the benefit more accessible than “help with anxiety”.

Healthcare may be defining access too narrowly

We usually define access in terms of cost, distance, and coverage. Those barriers are real. Both geography and financial circumstances affect health equity. But there is also a form of cognitive access: whether people know what’s available to them, and how it applies to them.

Continuing with mental health examples, I may have access to a coach and a therapist, but when should I seek help? The same applies to second opinions in cancer, or addressing prediabetes and switching to better-suited medications in chronic conditions.

When do I seek help? When do I prioritise it? Those questions linger because information can exist without becoming actionable.

I saw a similar problem in the early 2010s while working with a healthcare price-transparency platform. The obvious obstacle to that business model was that if someone breaks an ankle, they are not going to compare providers before going to the emergency room. That’s understandable. But a back surgery is different. In that scenario, many people did not realise they had options or that they could compare price and quality. 

A system can, therefore, be technically accessible and still hard to use. A 2025 study published in JAMA Network Open, conducted by Dr Christopher L. Cai and colleagues at Mass General Brigham and Harvard Medical School analysing data from 2017–2021, found that only about 54% of Medicare Advantage enrollees were aware of their dental and vision coverage, even though nearly all plans include those benefits.[1]

I see the same issue with cancer, where I currently work. A 2026 review published in The Oncologist put the share of people with cancer who seek a second opinion anywhere from about 6.5% to 42%, depending on the population studied.[2]

A 2025 article in CURE identified barriers including shock after diagnosis, concern about delaying treatment, information overload, and fear of offending the primary clinician.[3]

Yet, second opinions can significantly change care. In a Stanford virtual second-opinion programme that followed 657 patients, doctors recommended a change to the treatment plan in 53.8% of cases.[4] We can all agree that any cancer patient would want the best care possible – but wanting that, and understanding which benefits and services will deliver on that, are two entirely different journeys.

Complexity has consequences beyond patient experience

When a benefit goes unused, it is usually labelled an awareness problem. But awareness is only the beginning. Someone has to think: this applies to me, it could work in my life, and it’s worth committing to over everything else competing for my attention.

A touchpoint is more than saying “we’re live with the service”. It has to communicate something useful to people. Federal survey data supports this pattern. A 2025 data brief from the Office of the Assistant Secretary for Technology Policy found that 87% of people encouraged by their provider to use a patient portal accessed it, compared with 57% of those who were not.[5]

Healthcare is inherently complex, and some of that nuance has to stay.

The goal is not to over simplify it, but to make complexity understandable. That means delivering information in a way that makes sense within the context of someone’s life. Are we bringing people to our way of seeing the world, or meeting them where they are? Whatever we build, we should check that people understood it, not assume a message landed because it went out.

Clarity needs to be designed upstream

Clarity cannot be left to marketing at the end of the process. By then, much of the confusion may already be built into the enrolment steps, the labels, the screens, and the training.

Health policy shows what happens otherwise. An August 2026 analysis by Avalere Health, funded by PhRMA, found that 1% of the study population enrolled in the Medicare Prescription Payment Plan in 2025.[6] Real-time prescription benefit tools offer another example. A 2026 study published in the Journal of General Internal Medicine found that primary-care providers reported minimal training on real-time prescription benefit tools,[7] while a separate 2025 study of 2.8 million beneficiaries found no change in prescription spending or fills in the first year after clinician access was introduced.[8] The technology existed, but it was not designed around how people actually use it.

This is why clarity is not a marketing responsibility alone. Marketing can bring the perspective of the person on the other end, but product, clinical, operations, customer experience, and leadership all shape what that person encounters. Every touchpoint has to create value, and that has to be decided early, rather than patched in later.

Access without understanding is incomplete

Those of us in the healthcare industry have spent decades asking how more people can reach appropriate care. That’s meaningful to impact population health. The next question is whether, once they get there, we have designed the experience so they can understand it and use it.

Access and clarity should not be treated as separate problems. When organisations treat clarity as part of access, they improve the patient experience and increase the odds that clinical expertise, innovation, and investment turn into something people actually use.

References

[1] Cai CL, Iyengar S, Woolhandler S, et al. Use and costs of supplemental benefits in Medicare Advantage, 2017-2021. JAMA Network Open. 2025;8(1):e2454699. doi:10.1001/jamanetworkopen.2024.54699. Coverage in AJMC: https://www.ajmc.com/view/medicare-advantage-enrollees-underuse-dental-vision-hearing-benefits

[2] Patient-driven second opinions in oncology: a review. The Oncologist. 2026;31(8):oyag241. https://academic.oup.com/oncolo/article/31/8/oyag241/8733882

[3] The pros and cons of seeking a second opinion in cancer treatment. CURE, January 2025. https://www.curetoday.com/view/the-pros-and-cons-of-seeking-a-second-opinion-in-cancer-treatment

[4] Shah AP, et al. Online second-opinion program at Stanford Health Care (657 patients). JCO Oncology Practice, published February 11. Reported in: Online second opinions. Cancer Today, March 31, 2025. https://www.cancertodaymag.org/cancer-talk/online-second-opinions/

[5] Office of the Assistant Secretary for Technology Policy (ASTP)/ONC. Individuals' Access and Use of Patient Portals and Smartphone Health Apps, 2024. ASTP Data Brief No. 77, July 2025. https://healthit.gov/data/data-briefs/individuals-access-and-use-patient-portals-and-smartphone-health-apps-2024/

[6] Avalere Health. New analysis highlights opportunities to improve Medicare Prescription Payment Plan uptake. August 2026. Funded by PhRMA; Avalere retained editorial control. https://avalerehealth.com/thought-leadership/new-analysis-highlights-opportunities-to-improve-medicare-prescription-payment-plan-uptake/

[7] The promises and pitfalls of real-time benefit tools: a qualitative study of primary care providers. Journal of General Internal Medicine. 2026. doi:10.1007/s11606-026-10673-3. https://link.springer.com/article/10.1007/s11606-026-10673-3

[8] Prescription use and spending after the introduction of a real-time prescription benefit tool. 2025. PubMed ID 40608336. https://pubmed.ncbi.nlm.nih.gov/40608336/

About the author

Nicola Kamath is chief marketing officer at AccessHope. She helps healthcare and technology businesses define their market position and build the marketing teams and systems to support growth. Over nearly two decades, Kamath has built marketing and growth functions at early-stage ventures, high-growth companies, and public organisations. She has held leadership roles at Huddle Up, Ginger (now part of Headspace), Quartet Behavioral Health, Castlight Health, Simplee, and Phreesia. In healthcare, Kamath focuses on helping employers, health plans, and the people they serve understand the value of complex services and make informed decisions. She holds a BSc in Systems Engineering from the University of Illinois Urbana-Champaign and an MBA with a healthcare focus from Columbia Business School. She has served as an advisor to Stanford Brainstorm, Stanford University’s brain health innovation lab, and as an innovation leader with the American Psychiatric Association’s Psychiatric Innovation Lab.

Image
Nicola Kamath
profile mask

Nicola Kamath